News

In the final draft guidance rolled out by the National Institute for Health and Care Excellence- NICE, a single-dose therapy, eladocagene exuparvovec, has been recommended for patients who are more than 18 months old and happen to be suffering...

More than 150,000 Australians and 50 million people across the world are affected by epilepsy, with almost one-third finding it challenging to control the condition with the anti-seizure medications that are currently in use. The patients with such drug-resistant...

Radiology plays a huge role in healthcare today, providing diagnosis and treatment for all kinds of medical issues. It's fascinating to learn how it has developed over time, from its humble origins up to the present-day cutting-edge tools we're...

SGD Pharma, a global leader in glass pharmaceutical packaging, has been rated gold - indicating top 5% performance - following a rigorous sustainability assessment by EcoVadis, the world’s most trusted provider of business sustainability ratings. EcoVadis assesses companies in...

Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that the company will commence the construction of a fifth plant as part of its strategic expansion in response to increased market demand. The company will invest over KRW...

During its meeting in March 2023, the Management Board of the European Medicines Agency (EMA) gave an update on the continued efforts of the agency's Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) to further monitor...

The UK government intends to make clinical trials more accessible in order to re-establish the country's reputation as a favoured location for pioneering research. In a new initiative to jump-start the country's faltering life sciences goals, the Medicines and Healthcare...